David Loew is the CEO of Ipsen, a publicly listed, family-controlled specialty biopharma group with approximately 6,000 employees.
David Loew is the CEO of Ipsen, a publicly listed, family-controlled specialty biopharma group with approximately 6,000 employees, operations in 40 countries, and products in 100 countries. He joined Ipsen in July 2020 after serving as CEO of Sanofi Pasteur Vaccines since 2016. Loew has nearly thirty years of leadership and experience across various therapeutic areas and has worked in US, European, and international markets.
Full founder directory · Investor directory · Company funding database · Fundraising library